Development of new non-invasive tests for colorectal cancer screening: The relevance of information on adenoma detection

QR Code

Development of new non-invasive tests for colorectal cancer screening: The relevance of information on adenoma detection

Researchers are actively pursuing the development of a new non-invasive test (NIT) for colorectal cancer (CRC) screening as an alternative to fecal occult blood tests (FOBTs). The majority of pilot studies focus on the detection of invasive CRC rather than precursor lesions (i.e., adenomas). We aime...

Full description

Bibliographic Details
Main Authors:	Haug, U., Knudsen, A., Lansdorp_Vogelaar, Iris, Kuntz, K.
Format:	Journal Article
Published:	John Wiley & Sons, Inc. 2015
Online Access:	http://hdl.handle.net/20.500.11937/49977

Similar Items

Cost-effectiveness of colorectal cancer screening
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2011)

A systematic comparison of microsimulation models of colorectal cancer: The role of assumptions about adenoma progression
by: Kuntz, K., et al.
Published: (2011)

Colorectal cancer mortality prevented by use and attributable to nonuse of colonoscopy
by: Stock, C., et al.
Published: (2011)

Contribution of screening and survival differences to racial disparities in colorectal cancer rates
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2012)

Immunochemical faecal occult blood testing to screen for colorectal cancer: Can the screening interval be extended?
by: Haug, U., et al.
Published: (2016)

Validation of Models Used to Inform Colorectal Cancer Screening Guidelines
by: Rutter, C., et al.
Published: (2015)

European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition Introduction
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2012)

Colorectal cancer screening in Australia
by: Kuipers, E., et al.
Published: (2017)

Variation in adenoma detection rate and the lifetime benefits and cost of colorectal cancer screening: A microsimulation model
by: Meester, R., et al.
Published: (2015)

Cost-savings to medicare from pre-medicare colorectal cancer screening
by: Goede, S., et al.
Published: (2015)

Developing a score chart to improve risk stratification of patients with colorectal adenoma
by: Van Heijningen, E., et al.
Published: (2016)

Clarifying differences in natural history between models of screening: The case of colorectal cancer
by: Van Ballegooijen, M., et al.
Published: (2011)

Nonbleeding adenomas: Evidence of systematic false-negative fecal immunochemical test results and their implications for screening effectiveness - A modeling study
by: Van Der Meulen, M., et al.
Published: (2016)

Assessment of a cancer screening program
by: Rabeneck, L., et al.
Published: (2015)

Estimation of benefits, burden, and harms of colorectal cancer screening strategies: Modeling study for the US preventive services Task Force
by: Knudsen, A., et al.
Published: (2016)

Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2013)

Adherence to colorectal cancer screening: Four rounds of faecal immunochemical test-based screening
by: Van Der Vlugt, M., et al.
Published: (2017)

Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening
by: Wilschut, J., et al.
Published: (2011)

Optimal colorectal cancer screening in states' low-income, uninsured populations - The case of South Carolina
by: Van Der Steen, A., et al.
Published: (2015)

Faecal immunochemical tests versus guaiac faecal occult blood tests: What clinicians and colorectal cancer screening programme organisers need to know
by: Tinmouth, J., et al.
Published: (2015)

The value of models in informing resource allocation in colorectal cancer screening: The case of the Netherlands
by: Van Hees, F., et al.
Published: (2015)

Sojourn time of preclinical colorectal cancer by sex and age: Estimates from the german national screening colonoscopy database
by: Brenner, H., et al.
Published: (2011)

Colorectal cancer deaths attributable to nonuse of screening in the United States
by: Meester, R., et al.
Published: (2015)

Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening
by: Goede, S., et al.
Published: (2017)

Should colorectal cancer screening be considered in elderly persons without previous screening?: A cost-effectiveness analysis
by: Van Hees, F., et al.
Published: (2014)

Effects of Increasing Screening Age and Fecal Hemoglobin Cutoff Concentrations in a Colorectal Cancer Screening Program
by: Wieten, E., et al.
Published: (2016)

Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening
by: Goede, S., et al.
Published: (2013)

Fecal immunochemical test-based colorectal cancer screening: The gender dilemma
by: Grobbee, E., et al.
Published: (2017)

Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test
by: Meester, R., et al.
Published: (2016)

State disparities in colorectal cancer rates: Contributions of risk factors, screening, and survival differences
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2015)

Investigation into the controversial association of Streptococcus gallolyticus with colorectal cancer and adenoma.
by: Abdulamir, Ahmed Sahib, et al.
Published: (2009)

State disparities in colorectal cancer mortality patterns in the United States
by: Naishadham, D., et al.
Published: (2011)

How much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer?
by: Wilschut, J., et al.
Published: (2011)

Features of adenoma and colonoscopy associated with recurrent colorectal neoplasia based on a large community-based study
by: Van Heijningen, E., et al.
Published: (2013)

A randomised comparison of two faecal immunochemical tests in population-based colorectal cancer screening
by: Grobbee, E., et al.
Published: (2016)

Cost Effectiveness of Screening Individuals With Cystic Fibrosis for Colorectal Cancer
by: Gini, A., et al.
Published: (2018)

Integrating personalised genomics into risk stratification models of population screening for colorectal cancer
by: Cenin, Dayna, et al.
Published: (2017)

Adherence to surveillance guidelines after removal of colorectal adenomas: A large, community-based study
by: van Heijningen, E., et al.
Published: (2015)

Costs and outcomes of Lynch syndrome screening in the Australian colorectal cancer population
by: Cenin, Dayna, et al.
Published: (2018)

Attendance and diagnostic yield of repeated two-sample faecal immunochemical test screening for colorectal cancer
by: Kapidzic, A., et al.
Published: (2015)

Cannot write session to /tmp/vufind_sessions/sess_sg3nsemlvepamjdmdamlqv5tpu